EQS-News: European Healthcare Acquisition & Growth Company B.V. publishes its Annual Report 2022
EQS-News: European Healthcare Acquisition & Growth Company B.V.
- EQS-News: European Healthcare Acquisition & Growth Company B.V.
European Healthcare Acquisition & Growth Company B.V. publishes its Annual Report 2022 (news with additional features)
The issuer is solely responsible for the content of this announcement. - European Healthcare Acquisition & Growth Company B.V. publishes its annual report for the financial year 2022
Today, European Healthcare Acquisition & Growth Company B.V. ("EHC"), a Dutch operators-led special purpose acquisition company listed on Euronext Amsterdam that announced on 22 December 2022 that it signed a business combination agreement with Austrian-based Croma-Pharma GmbH, publishes its annual report for the financial year 2022 (the "Annual Report 2022"), including its financial statements and the report of its board. - The Annual Report 2022 relates to the financial year 2022, from 1 January 2022 to 31 December 2022, a period prior to completion of the proposed business combination of EHC with Croma-Pharma GmbH.
- The Annual Report 2022 therefore does not comprise any accounts or results of Croma-Pharma GmbH.